Oncology ImagingArchives
Non-metastatic castration-resistant prostate cancer in the epoch of PSMA-ligand PET/CT: twilight?
Oncology Imaging 1 min.
Oncology Imaging
1 min.
Published on 31/07/2026 |
Original article (Full-text)
| Valsamaki, Pipitsa N. et al. | Annals of Nuclear Medicine. Volume 40(8).
The introduction of prostate-specific membrane antigen-ligand positron emission tomography/computerised tomography (PSMA-ligand PET/CT) into clinical practice has altered the prevalence of non‑metastatic (by conventional imaging) castration-resistant prostate cancer (nmCRPC). We herewith briefly...
Generative AI for spatial tumor growth on MRI: a proof-of-principle study in pediatric diffuse midline glioma
Oncology Imaging 1 min.
Oncology Imaging
1 min.
Published on 24/07/2026 |
Original article (Full-text)
| Laslo, Daria et al. | BMC Medicine. Volume 24(1).
Magnetic resonance imaging (MRI) is a cornerstone of non-invasive diagnosis and response monitoring in neuro-oncology, and predictions of spatial tumor progression conditioned on the patients' anatomy are increasingly important. We present a proof-of-principle of personalized spatial tumor progression...
